pharma · Acute Ischemic Stroke · Chronic Kidney Disease · DMAC
DiaMedica Therapeutics
DiaMedica Therapeutics clinical programs — 3 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Minneapolis, USA HQ
45 Employees
Public company Type
DMAC · NYSE Ticker
Company details
- Status
- Public
- HQ
- Minneapolis, USA
- Employees
- 45
- Programs
- 8
- Drugs
- 7
- Patents
- 9
DiaMedica Therapeutics projects
3 ClinicalTrials.gov programs sponsored by DiaMedica Therapeutics.
DiaMedica Therapeutics has 3 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
Frequently asked questions
How many clinical projects does DiaMedica Therapeutics have?
3 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.